Jasper Therapeutics Inc.

AI Score

0

Unlock

0.15
-0.02 (-11.56%)
At close: Jan 15, 2025, 12:42 PM

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19
Revenue n/a n/a n/a n/a n/a
Cost of Revenue 1.11M 1.31M 566.00K 21.00K n/a
Gross Profit -1.11M -1.31M -566.00K -21.00K n/a
Operating Income -68.86M -51.20M -36.83M -20.68M -4.71M
Interest Income 5.20M n/a n/a n/a 533.00
Pretax Income -66.09M -37.69M -30.64M -31.67M -4.99M
Net Income -64.47M -24.17M -23.98M -31.67M -4.99M
Selling & General & Admin 17.08M 16.57M 11.41M 4.80M 1.09M
Research & Development 51.78M 34.63M 25.42M 15.88M 3.62M
Other Expenses n/a 586.00K -80.00K -111.00K n/a
Operating Expenses 68.86M 51.20M 36.83M 20.68M 4.45M
Interest Expense n/a n/a n/a n/a n/a
Selling & Marketing Expenses n/a n/a n/a n/a n/a
Cost & Expenses 68.86M 51.20M 36.83M 20.68M 4.45M
Income Tax -1.63M -13.51M -6.65M -38.45K -277
Shares Outstanding (Basic) 10.44M 3.65M 1.14M 277.07K n/a
Shares Outstanding (Diluted) 10.44M 3.65M 1.14M 277.07K n/a
EPS (Basic) -6.18 -6.63 -21.05 -114.3 n/a
EPS (Diluted) -6.18 -6.63 -21.05 -114.3 n/a
EBITDA -64.98M -38.21M -31.17M -31.95M -277.00K
Depreciation & Amortization 1.11M 1.31M 566.00K 21.00K 4.71M